首页> 外文期刊>Journal of Pediatric Sciences >Role of Cytokines in Children with Obstructive Sleep apnea
【24h】

Role of Cytokines in Children with Obstructive Sleep apnea

机译:细胞因子在儿童阻塞性睡眠呼吸暂停中的作用

获取原文
           

摘要

Aim: To explore the inflammatory and anti-inflammatory factors in children with and without obstructive sleep apnea (OSA) and observe the effects of these factors after treatment in children with OSA. Methods: A total of 142 children were enrolled in this study. Based on overnight polysomnographic evaluation and physical examination, they were divided into two groups; OSA group (47) and control group (95). OSA was diagnosed if obstructive apnea index (OAI) >1. According to apnea-hypoapnea index (AHI), OSA children were further divided into mild (AHIa‰¥1 anda‰¤5), moderate (AHI>5 anda‰¤10), and severe (AHI>10) groups. A blood sample was collected for analysis of interleukin 6 (IL-6), intracellular adhesion molecule 1 (ICAM-1), and interleukin 10 (IL-10). Results: Serum levels of IL-6 and ICAM-1 were significantly higher and serum level of IL-10 was significantly lower in OSA group compared to control group. Of 47 OSA children, 43 received treatment (38 underwent adenotonsillectomy (T&A); 4 received inhaled nasal corticosteroid; and 1 received noninvasive positive pressure ventilation (NIPPV); 7 lost during follow-ups, remaining 36 were followed up after three months. There was substantial decrease in IL-6 and ICAM-1 and increase in IL-10 after treatment (P<0.01). The difference was statistically significant (P<0.05), independent of age, gender, and body mass index (BMI). Conclusion: Up-regulation of pro-inflammatory cytokines have been well established in childhood OSA, but down-regulation of anti-inflammatory cytokine IL-10 and its up-regulation following treatment is a new finding; all of which in turn could promote the onset and progression of atherogenesis in children. As this inflammatory response is reversible, early recognition and treatment of OSA children would be beneficial in decreasing the risks.
机译:目的:探讨有无阻塞性睡眠呼吸暂停(OSA)患儿的炎症和抗炎因素,并观察这些因素对OSA患儿治疗后的影响。方法:本研究共纳入142名儿童。根据通宵多导睡眠图评估和体格检查,将他们分为两组。 OSA组(47)和对照组(95)。如果阻塞性呼吸暂停指数(OAI)> 1,则诊断为OSA。根据呼吸暂停低通气指数(AHI),OSA儿童又分为轻度(AHIa≥¥ 1和a‰¤5),中度(AHI> 5和a≥¤10)和重度(AHI> 10)组。收集血液样本以分析白介素6(IL-6),细胞内粘附分子1(ICAM-1)和白介素10(IL-10)。结果:OSA组的血清IL-6和ICAM-1水平明显高于对照组,IL-10的血清水平明显低于对照组。在47位OSA儿童中,有43位接受了治疗(38位接受了腺扁桃体切除术(T&A); 4位接受了吸入性鼻皮质激素治疗; 1位接受了无创正压通气(NIPPV);在随访过程中失掉7例,三个月后随访了36例。治疗后IL-6和ICAM-1显着降低,IL-10升高(P <0.01),差异有统计学意义(P <0.05),与年龄,性别和体重指数(BMI)无关。结论:在儿童OSA中已经确定了促炎细胞因子的上调,但是抗炎细胞因子IL-10的下调及其在治疗后的上调是一个新发现;所有这些都可以促进由于这种炎症反应是可逆的,因此早期识别和治疗OSA儿童将有助于降低患病风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号